JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: MLN-4760 is a novel, potent and selective human angiotensin-converting (ACE2) inhibitor with IC50 of 0.44 nM and with excellent selectivity (> 5000-fold) versus related enzymes including human testicular ACE (IC50, > 100 uM) and bovine carboxypeptidase A (CPDA; IC50, 27 uM). In huMNCs, MLN-4760-B detected 63% ACE2 with 28-fold selectivity over ACE.
References:
1. DalesNA, et al. Substrate-based design of the first class ofangiotensin-converting enzyme-related carboxypeptidase (ACE2)inhibitors. J Am Chem Soc. 2002 Oct 9; 124(40):11852-3.
2. JoshiS, et al. Angiotensin converting enzyme versus angiotensin convertingenzyme-2 selectivity of MLN-4760 and DX600 in human and murine bonemarrow-derived cells. Eur J Pharmacol. 2016 Mar 5; 774:25-33.
3. BennionDM, et al. Activation of the Neuroprotective Angiotensin-ConvertingEnzyme 2 in Rat Ischemic Stroke. Hypertension. 2015 Jul; 66(1):141-8.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Delivery expected until 7/4/2024
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!